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Talc pleurodesis induces a strong local inﬂammatory reaction which can be detected by PET scan for years after the procedure.
When patients undergo PET scanning in the workup of a suspected malignancy later in life, pleural FDG uptake may unnecessarily
lead to an additional invasive diagnostic workup. We present two cases of positive pleural PET ﬁndings more than 10 years after
talc pleurodesis, where we adopted a watchful waiting approach. Positive pleural PET ﬁndings as a result of prior talc pleurodesis
should always be included in the diﬀerential diagnosis of pleural abnormalities.
Copyright © 2009 Hilke Peek et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Talc pleurodesis is considered to be a safe and eﬀective
treatment modality in the management of (recurrent) spon-
taneouspneumothorax.Inliterature,increasedpleuralFDG-
uptake on PET scanning is described for up to ﬁve years
after the initial procedure [1–3]. Often, a malignant pleural
disease is suspected, and patients undergo an extensive and
invasive diagnostic workup. We present the cases of two
patients whose PET scans revealed increased pleural uptake
more than ten years after talc pleurodesis, without any signs
of malignancy or infection at follow-up.
2. Case Presentation
2.1. Patient 1. A 50-year-old man, heavy smoker, was found
to have an abnormal chest X-ray, performed by his gastro-
enterologist in the work up of abdominal complaints. His
medical history was signiﬁcant for a left-sided pneumoth-
orax 10 years ago. At that time an uncomplicated thoraco-
scopic talc pleurodesis procedure was performed. Computed
tomographic (CT) scan showed multiple nodular thickening
of the posteromedial pleura on the left side. Positron
emission tomography (PET) demonstrated high glucose
uptake in all these lesions (Figure 1). Benign granulomatous
inﬂammation after talc pleurodesis was suspected and we
decided to perform follow-up CT-scans every 4 months.
The areas of pleural FDG uptake have remained stable since
and the patient is well, without any signs of malignancy
or infection, 16 months after the initial PET scan. His
presenting abdominal complaints were found to be the result
of pancreatitis.
2.2. Patient 2. A 57-year-old woman presented with a lesion
in the apex of the right upper lobe, found on routine
chest X-ray. Medical history was signiﬁcant for a right-sided
pneumothorax for which she underwent talc pleurodesis 11
years ago, and a smoking status of more than twenty pack
years. CT-scan showed signs of emphysema and multiple
right-sided (sub)pleurally localised lesions, and a larger
apical pleural plaque. All lesions had increased pleural FDG
uptake (Figure 2). The abnormalities on CT and PET scan
were deemed the result of the prior talc pleurodesis. Follow-
up CT scans showed no changes of the pleural lesions, and
the patient remains well 16 months after initial CT-scan.
3. Discussion
Talc pleurodesis is used widely for treatment of patients
with persistent pleural eﬀusions or pneumothorax not2 Case Reports in Medicine
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amenable to other treatment options. The pleural inﬂam-
matory response to talc administration is considered to be
responsible for its ability to cause pleurodesis. Pathologic
studies have indeed demonstrated a strong inﬂammatory
reaction of both the visceral and parietal pleura following
pleural talc administration, leading to the formation of
pleural talc granulomata and eventually pleural ﬁbrosis [1,
4].
Increased pleural FDG uptake on PET scanning after talc
administration was ﬁrst described by Murray et al. [1], ten
months after pleurodesis. A more recent study showed the
presence of PET-positive subpleural talc granulomas up to
ﬁve years after pleurodesis [2]. The question indeed rises;
how long will talc induced pleurodesis be detectable by PET?
As these two cases suggest, this could be well for more than
ten years.
In conclusion, these cases stress the importance of long-
term persistent pleural inﬂammation after talc pleurodesis.
As such, benign positive pleural PET ﬁndings in a patient
with a history of talc pleurodesis should always be included
in the diﬀerential diagnosis of pleural abnormalities, even if
the original procedure was performed more than a decade
ago.
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